Staff Members - Benha University
Serum TWEAK in acne vulgaris: An unknown soldier
• 2019
Publication Information
Authors
Abd El‐Aziz Ibrahim El‐Taweel MD1 | Rehab Mohammed Salem MD1 |
Amira Mohamed Noureldin Abdelrahman MD2 | Basma Abd El‐Kafy Mohamed MBBCH3
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: TWEAK is an inflammatory cytokine which is involved in the development
of many inflammatory disorders.
Aims: This study aimed to evaluate serum levels of TWEAK in patients with acne
vulgaris.
Subjects and Methods: This case‐controlled study included 100 acne vulgaris patients
divided into two groups. Group 1 included 25 patients with moderate acne and
25 patients with severe acne. Group 2 consisted of 50 acne‐free control subjects.
Acne was graded by the Global Acne Grading System (GAGS). Serum TWEAK was
measured by ELISA kits.
Results: Acne patients had significant elevation in TWEAK serum levels when compared
to the control subjects (P < 0.001). TWEAK serum levels did not show significant
difference regarding disease grade, postacne scar, and hyperpigmentation (P
value = 0.43, 0.37, 0.80, 0.67, respectively). TWEAK levels were not affected by any
of the studied variables except for the significant negative correlation between its
levels and the disease duration in severe acne group only (r = −0.42, P = 0.03).
Conclusion: TWEAK may be involved in acne vulgaris development, but more studies
are needed to clarify its role.
of many inflammatory disorders.
Aims: This study aimed to evaluate serum levels of TWEAK in patients with acne
vulgaris.
Subjects and Methods: This case‐controlled study included 100 acne vulgaris patients
divided into two groups. Group 1 included 25 patients with moderate acne and
25 patients with severe acne. Group 2 consisted of 50 acne‐free control subjects.
Acne was graded by the Global Acne Grading System (GAGS). Serum TWEAK was
measured by ELISA kits.
Results: Acne patients had significant elevation in TWEAK serum levels when compared
to the control subjects (P < 0.001). TWEAK serum levels did not show significant
difference regarding disease grade, postacne scar, and hyperpigmentation (P
value = 0.43, 0.37, 0.80, 0.67, respectively). TWEAK levels were not affected by any
of the studied variables except for the significant negative correlation between its
levels and the disease duration in severe acne group only (r = −0.42, P = 0.03).
Conclusion: TWEAK may be involved in acne vulgaris development, but more studies
are needed to clarify its role.